Glaucoma epidemiology in the Russian Federation
https://doi.org/10.21516/2072-0076-2024-17-3-7-12
Abstract
Glaucoma is worldwide the most common cause of irreversible blindness. Its prevalence in the population older than 40 years is about 3.5 %, and correlates with age. The most common type is primary open-angle glaucoma (POAG). The global prevalence of POAG is expected to grow from 76.0 million in 2020 to 111.8 million by 2040. In 2022, a total of 1,250,558 patients with glaucoma were registered in the Russian Federation, of which 110,680 had newly diagnosed glaucoma. The overall glaucoma incidence rate in Russia shows a steady growth: in 2022, it increased by 30 % as compared to 2013. In order to meet the challenge, medical care of glaucomatous patients is on the rise: the contingent receiving dispensary observation increased by 6.8 % over the last 10 years, whilst surgical treatment involved 28.1 % more patients.
About the Authors
V. V. Neroev
Helmholtz National Medical Research Center of Eye Diseases; A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
Vladimir V. Neroev — Academician of RAS, Dr. of Med. Sci., professor, director, Helmholtz National Medical Research Center of Eye Diseases; head of chair of eye diseases of the faculty of additional professional education, A.I. Evdokimov Moscow State University of Medicine and Dentistry.
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062; 20, Bldg.1, Delegatskaya St., Moscow, 127473
L. A. Mikhaylova
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation
Russian Federation
Ludmila A. Mikhaylova — Director assistant in clinical and organizing activity, 3rd degree state advisor.
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
T. N. Malishevskaya
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation
Russian Federation
Tatiana N. Malishevskaya — Dr. of Med. Sci., head of the department of analytics.
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
S. Yu. Petrov
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation
Russian Federation
Sergey Yu. Petrov — Dr. of Med. Sci., head of the glaucoma department.
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
O. M. Filippova
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation
Russian Federation
Olga M. Filippova – Cand. of Med. Sci., researcher, glaucoma department.
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
References
1. European Glaucoma Society. Terminology and guidelines for glaucoma. 5th edition: Savona, Italy PubliComm; 2020.
2. Clinical Gidelines “Primary open angle glaucoma”. 2020 (16.02.2021), approved by the Ministry of Health of the Russian Federation (In Russ.).
3. Nesterov A.P. Glaucoma. Moscow: Medicine; 1995 (In Russ.).
4. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90 (3): 262–7. doi:10.1136/bjo.2005.081224
5. Neroev V.V. Ophthalmological morbidity in Russia. In: Avetisov S.E., Egorov E.A., Moshetova L.K., Takhchidi Kh.P., eds. Ophthalmology. National Guide. Moscow: GEOTAR-Media; 2018: 15–9 (In Russ.).
6. Jonas JB, Aung T, Bourne RR, et al. Glaucoma. Lancet. 2017; 390 (10108): 2183–93. doi:10.1016/S0140-6736(17)31469-1
7. World report on vision. World Health Organization. 2019 [29.02.2024]. Available at: https://cdn.who.int/media/docs/default-source/blindness-and-visual-impairment/9789241516570-eng.pdf?sfvrsn=dd15adbb_3
8. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121 (11): 2081–90. doi:10.1016/j.ophtha.2014.05.013
9. Chou R, Selph S, Blazina I, et al. Screening for glaucoma in adults: Updated evidence report and systematic review for the US preventive services task force. JAMA. 2022; 327 (20): 1998–2012. doi:10.1001/jama.2022.6290
10. Neroev V.V., Kiseleva O.A., Bessmertny A.M. Main results of a multicenter study of the epidemiological features of primary open-angle glaucoma in the Russian Federation. Russian ophthalmological journal. 2013; 6 (3): 4–7 (In Russ.).
11. Friedman DS, Nordstrom B, Mozaffari E, Quigley HA. Glaucoma management among individuals enrolled in a single comprehensive insurance plan. Ophthalmology. 2005; 112 (9): 1500–04. doi:10.1016/j.ophtha.2005.02.030
12. Li T, Lindsley K, Rouse B, et al. Comparative effectiveness of first-line medications for primary open-angle glaucoma: A systematic review and network meta-analysis. Ophthalmology. 2016; 123 (1): 129–40. doi:10.1016/j.ophtha.2015.09.005
13. Musch DC, Lichter PR, Guire KE, Standardi CL. The collaborative initial glaucoma treatment study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999; 106 (4): 653–62. doi:10.1016/s0161-6420(99)90147-1
14. Morbidity rate of the entire population of Russia in 2022: Ministry of Health of the Russian Federation Federal State Budgetary Institution “Central Research Institute for Organization and Informatization of Health Care”; 2022 (In Russ.).
15. General morbidity rate of the entire population of Russia in 2022: Ministry of Health of the Russian Federation Federal State Budgetary Institution “Central Research Institute of Organization and Informatization of Health Care”; 2022 (In Russ.).
16. Federal statistical observation reporting forms No. 12 “Information on the number of diseases registered in patients living in the service area of a medical organization” for 2022 (In Russ.).
17. Zhang N, Wang J, Li Y, Jiang B. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Sci Rep. 2021; 11 (1): 13762. doi:10.1038/s41598-021-92971-w
Review
For citations:
Neroev V.V., Mikhaylova L.A., Malishevskaya T.N., Petrov S.Yu., Filippova O.M. Glaucoma epidemiology in the Russian Federation. Russian Ophthalmological Journal. 2024;17(3):7-12. (In Russ.) https://doi.org/10.21516/2072-0076-2024-17-3-7-12
Views:
1187
Email this article 